Clinical Trial Update: Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program [Phase 4]

View source ↗

Summary

Phase 4 trial comparing regional citrate anticoagulation with fixed-dose versus adjusted citrate program in critical illness and kidney replacement contexts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Kidney Replacement Therapy

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Critical Illness, Kidney Replacement Disorder | Phase 4 | Status: COMPLETED